The Clinical Value of no-Reflow Phenomenon in the Routing Operation of The Regional Vascular Center

Coronary no-reflow phenomenon (CNR) is a complication of primary percutaneous coronary intervention (PCI). According to different reports, CNR occurs in 10 to 60 % of cases. Despite the long history of studying this phenomenon many issues remain unsolved. This article presents a clinical case of electrocardiographically confirmed ST-segment elevation myocardial infarction. In this case, the CNR phenomenon occurred during PCI and was associated with heart rhythm disorders, left ventricular (LV) cavity dilatation with a decrease in LV contractility, and formation of intracavitary thrombus. The patient asked for medical care late, which could influence the development of CNR. This case demonstrates the clinical significance, diagnostic characteristics, and successful drug correction of the no-reflow phenomenon.

No-reflow phenomenon, ST-segment elevation myocardial infarction, primary percutaneous coronary intervention, complications

1. Alekyan B.G., Abrosimov A.V. Complications of percutaneous coronary interventions. In: X-ray endovascular surgery. National leadership. ed. B.G. Alekyan. Vol. 2. Coronary heart disease-M.: GEOTAR-Media;2017. 399–445. [Russian: Алекян Б.Г., Абросимов А.В. Осложнения при чрескожных коронарных вмешательствах. В кн: Рентгенэндоваскулярная хирургия. Национальное руководство. Под ред. Б.Г. Алекяна. Т. 2. Ишемическая болезнь сердца. - М.: ГЭОТАР-Медиа; 2017. 399-445]

2. Protopopov A.V. Percutaneous coronary interventions in patients with acute myocardial infarction with ST segment elevation. In: X-ray endovascular surgery. National leadership. ed. B.G. Alekyan. Vol. 2. Coronary heart disease-M.: GEOTAR-Media;2017. 507–514 [Russian: Протопопов А.В. Чрескожные коронарные вмешательства у больных острым инфарктом миокарда с подъемом сегмента ST. В кн: Рентгенэндоваскулярная хирургия. Национальное руководство. Т. 2. Ишемическая болезнь сердца. Под ред. Б.Г. Алекяна. - М.: ГЭОТАР-Медиа, 2017.507–514]

3. Bouleti C, Mewton N, Germain S. The no-reflow phenomenon: State of the art. Archives of Cardiovascular Diseases. 2015;108(12):661–74. DOI: 10.1016/j.acvd.2015.09.006

4. Fajar JK, Heriansyah T, Rohman MS. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis. Indian Heart Journal. 2018;70:S406–18. DOI: 10.1016/j.ihj.2018.01.032

5. Kloner RA, Ganote CE, Jennings RB. The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the Dog. Journal of Clinical Investigation. 1974;54(6):1496–508. DOI: 10.1172/JCI107898

6. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial No-Reflow in Humans. Journal of the American College of Cardiology. 2009;54(4):281–92. DOI: 10.1016/j.jacc.2009.03.054

7. Wang L, Liu G, Liu J, Zheng M, Li L. Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention. Therapeutics and Clinical Risk Management. 2016;12:1017–22. DOI: 10.2147/TCRM.S107808

8. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. Journal of the American College of Cardiology. 2000;36(4):1202–9. DOI: 10.1016/S0735-1097(00)00865-2

9. Papapostolou S, Andrianopoulos N, Duffy SJ, Brennan AL, Ajani AE, Clark DJ et al. Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multicentre Australian registry. EuroIntervention. 2018;14(2):185–93. DOI: 10.4244/EIJ-D-17-00269

10. Cheng C, Liu X-B, Bi S-J, Lu Q-H, Zhang J. Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. PLOS ONE. 2019;14(8):e0220654. DOI: 10.1371/journal.pone.0220654

11. The TIMI Study Group*. The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings. New England Journal of Medicine. 1985;312(14):932–6. DOI: 10.1056/NEJM198504043121437

12. Tereshchenko A.S., Merkulov Е.V., Samko A.N. Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention. Rational Pharmacotherapy in Cardiology. 2019;15(6):918–27. [Russian: Терещенко А.С., Меркулов Е.В., Самко А.Н. Применение ингибиторов гликопротеиновых IIb/IIIa рецепторов у пациентов с инфарктом миокарда с подъемом сегмента ST и первичным чрескожным коронарным вмешательством. Рациональная Фармакотерапия в Кардиологии. 2019;15(6):918-27]. DOI: 10.20996/1819-6446-2019-15-6-918-927

13. Alekseeva Ya.V., Vyshlov E.V., Ussov V.Yu., Markov V.A. Microvascular injury phenomena in myocardial infarction. Siberian Medical Journal (Tomsk). 2018;33(4):19–26. [Russian: Алексеева Я.В., Вышлов Е.В., Усов В.Ю., Марков В.А. Феномены микрососудистого повреждения при остром инфаркте миокарда. Сибирский медицинский журнал (Томск). 2018;33(4):19-26]. DOI: 10.29001/2073-8552-2018-33-4-19-26

14. van ‘t Hof AWJ, Liem A, Suryapranata H, Hoorntje JCA, de Boer M-J, Zijlstra F. Angiographic Assessment of Myocardial Reperfusion in Patients Treated with Primary Angioplasty for Acute Myocardial Infarction: Myocardial Blush Grade. Circulation. 1998;97(23):2302–6. DOI: 10.1161/01.CIR.97.23.2302

15. Nab MH, Mostafa Sh, Elrabat Kh, Kabil H, Elmelegy N. Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction. Rational Pharmacotherapy in Cardiology. 2019;15(1):17–28. [Russian: Наб М.Х., Мостафа Ш., Эльрабат Х., Кабил Х., Элмелеги Н. Сравнение болюсного интракоронарного и болюсного внутривенного путей введения эптифибатида во время первичного чрескожного коронарного вмешательства у пациентов с передним инфарктом миокарда с подъемом сегмента ST. Рациональная Фармакотерапия в Кардиологии 2019;15(1):17-28]. DOI: 10.20996/1819-6446-2019-15-1-17-28

16. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119–77. DOI: 10.1093/eurheartj/ehx393

17. Ministry of Health of the Russian Federation. Acute myocardial infarction with elevation of the ST segment of the electrocardiogram. Clinical recommendations. 2016. [Russian: Министерство здравоохранения Российской Федерации. Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Клинические рекомендации. 2016. Доступно на: http://cr.rosminzdrav.ru/#!/ schema/135]